Amalgam Rx Partners with UCB for New Digital Health Solution

MHW can confirm that Allay Rx — a subsidiary of Amalgam Rx, Inc. — a leading digital therapeutics company, has cemented a partnership on a comprehensive behavioral and patient support program, BEYOND, for patients living with psoriasis and psoriatic arthritis.

BEYOND is a mobile application and provides patients with a trusted source of information, tools, and support. The app is designed to help people living with psoriasis and psoriatic arthritis reduce stress and improve resilience while living and dealing with the physical and psychological burden of the diseases.

Psoriasis and psoriatic arthritis are chronic auto-immune conditions affecting millions of people globally. Stress can be a common trigger for many patients living with these diseases because it increases inflammation, which can worsen symptoms and cause new flare-ups. Growing evidence indicates that the same processes that trigger inflammation in psoriatic disease also creates changes in the brain that affect emotional states. A study published in the journal Archives of Dermatology found that those living with psoriasis have a 39 percent greater risk of being diagnosed with depression and a 31 percent risk of anxiety than those without the disease.

“Living with psoriasis is a stressful and isolating experience for people. They feel embarrassed and self-conscious about their very visible and often misunderstood disease,” said Andrew Blauvelt, MD, MBA, president and investigator at Oregon Medical Research Center in Portland, OR. “Psychological factors can be as big a determinant of disability in patients as can skin disease severity and location, which is why it is so important to address the emotional and social problems patients are experiencing. In fact, research has found that stress makes psoriasis worse. All patients with psoriasis deserve to be treated with the best available therapies and receive the emotional support they need.”

To learn more about BEYOND, click here.

This post was written by:

- who has written 2292 posts on mHealthWatch.


Contact the author

0 comments
Advert